Please view in portrait
Diality is proud to introduce the Moda-flx Hemodialysis System, a hemodialysis platform designed to empower healthcare professionals to choose:
The Moda-flx Hemodialysis System helps healthcare professionals prioritize patients. Healthcare professionals should be able to choose one easy-to-use hemodialysis system to satisfy a broad range of dialysis prescriptions and maximize clinical flexibility.
Diality is developing a hemodialysis system that will enable physicians to prioritize patients while also helping their practice thrive and grow. Healthcare professionals should be able to choose one hemodialysis system to satisfy a broad range of dialysis prescriptions without compromising based on where dialysis is delivered. Our machine is being designed to empower healthcare professionals to choose:
Simplicity and Mobility
Diality’s goal is to reduce the burden of care for all dialysis stakeholders. Our system is being designed to be easy-to-use and intuitive, which can shorten training time, even for non-nephrology clinicians. The system will also be mounted on a custom cart for movement within any facility.
Intelligence
Patients and patient safety are at the forefront of everything we do at Diality. Our system aims to prioritize patient safety not only through design and engineering, but also by providing clinicians the information they need to make data-driven decisions about their patients’ care. Securely storing data to the cloud while maintaining accessibility via physician portal will help create a more personalized dialysis treatment experience for all dialysis stakeholders.
See how the Moda-flx Hemodialysis System fits into a care setting by tapping on the AR icon.
Diality is hiring!
Click below to join our team.
IRVINE, Calif.--(BUSINESS WIRE)--Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-flx Hemodialysis System Read the full press release here
IRVINE, Calif.--(BUSINESS WIRE)--Diality Inc. today announced that three posters highlighting new data from the first clinical use of the Moda-flx™ Hemodialysis System will be presented during the American Society of Nephrology’s Kidney Week 2025 in Houston, Texas. Read the full press release here
IRVINE, Calif.--(BUSINESSWIRE)-- Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced the first patient treatment in its PRESCRIBE Diality Home Hemodialysis Clinical Trial in partnership with aQua Research Institute and aQua Dialysis in Houston, Texas.
Diality is conducting the PRESCRIBE Diality trial under an Investigational Device Exemption (IDE) to evaluate a home use indication for the Moda-flx Hemodialysis System. The Moda-flx Hemodialysis System received U.S. Food and Drug Administration (FDA) clearance for use in professional care settings in August 2024. Read the full press release here.
